800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| BHG Lexington Treatment Center | 455 Park Place Ste 130 | Lexington |
| Ridge Behavioral Health System | 3050 Rio Dosa Drive | Lexington |
| Bluegrass Narcotics Addictions Program | 201 Mechanic St. | Lexington |
| Lexington Professional Associates, PLC | 340 Legion Drive | Lexington |
| BHG Berea Treatment Center | 1000 Ace Drive | Berea |
| Center for Behavioral Health – Richmond | 1018 Ival James Blvd Suite C | Richmond |
| Center For Behavioral Health | 2225 Lawrenceburg Road | Frankfort |
No results found!
MOUD treatment in Lexington: methadone, buprenorphine, and naltrexone
Lexington sits at the center of Kentucky’s Bluegrass region, and Fayette County is one of the better-served parts of the state for opioid use disorder care, with both opioid treatment programs (for methadone) and office-based prescribers who handle buprenorphine and naltrexone. That matters because access here does not depend on a single clinic type. If you are deciding to start treatment, or restarting after a gap, the listings above show programs in and around Lexington. You can call one directly or use the helpline on this page to talk through options.
What each medication is, and where you get it
Three medications are approved to treat opioid use disorder, and they are dispensed in different settings. Knowing which is which tells you what the listings above actually represent.
Methadone is a full opioid agonist that steadies the brain’s opioid receptors, easing withdrawal and cravings. For opioid use disorder it is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy. Dosing starts daily and can move to take-home doses as treatment stabilizes.
Buprenorphine, including Suboxone and other buprenorphine-naloxone products and the extended-release monthly injection Sublocade, is a partial agonist with a built-in ceiling that lowers overdose risk. Since 2023, any clinician with a standard DEA registration can prescribe it, so you can get it in a doctor’s office (office-based opioid treatment, or OBOT) and fill it at a pharmacy, or through an OTP. Kentucky removed Medicaid prior authorization for the combination tablet in 2019, which widened office-based access here.
Naltrexone, including the monthly Vivitrol injection, blocks opioid effects and is not itself an opioid. Any licensed prescriber can order it, but you have to be fully off opioids for a set period first to avoid sudden withdrawal. If you want to weigh the two most common options, this breakdown of how methadone and Suboxone compare covers the trade-offs, and this overview of what an OTP does day to day explains the clinic side.
Starting treatment and what the first visit looks like
The first step is an intake assessment: a clinician reviews your history, current use, and health, then works out a medication plan with you. Kentucky prescribers also check the KASPER prescription monitoring database and, for buprenorphine, obtain informed consent before starting. If you are using fentanyl, timing matters for buprenorphine: starting it too soon after fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans the first dose with you rather than rushing it. Methadone induction does not carry that same timing problem. Some programs offer same-day or next-day starts; ask when you call. For more on beginning care after fentanyl use, see starting methadone treatment when fentanyl is involved, and this guide to opioid use disorder treatment overall covers the wider picture.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 expanded take-home methadone, up to a 28-day supply for patients who are stable in treatment, on a graduated schedule earlier on. The same update allowed treatment to start by telehealth and removed the old requirement that you have a year-long history of opioid addiction before an OTP could admit you. Take-home eligibility is decided by the program based on how stable you are. As of July 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for opioid use disorder remains dispensed through an OTP. If you are transferring in or coming back, staying consistent with your dose matters, as this explainer on holding a steady methadone dose lays out.
Paying for treatment in Kentucky
Kentucky Medicaid covers all three FDA-approved medications for opioid use disorder, methadone, buprenorphine, and naltrexone, and delivers benefits through managed care plans that all cover MOUD as a core service. Kentucky removed prior authorization for the buprenorphine-naloxone combination tablet in February 2019, which cut a common delay to starting office-based care. If you have private insurance or Medicare, MOUD is generally covered, though methadone coverage varies more by private plan than buprenorphine does. Many OTPs also offer self-pay and sliding-scale options. Program costs vary, so ask each clinic directly what it charges and what your plan covers.
The overdose picture in Fayette County
Fatal overdoses in Fayette County fell from 177 in 2023 to 120 in 2024, a decline the city credited to expanded medication treatment, peer recovery support, and harm reduction (City of Lexington, 2025). Statewide, fentanyl was involved in about 62 percent of Kentucky’s 2024 overdose deaths (Lexington-Fayette County Health Department, 2025), and Kentucky overall saw a large drop in deaths that year. Numbers like these represent real losses in the community, and they are also a sign that treatment and outreach are reaching people. If you are weighing whether care works, that trend is part of the answer, and the next step is on this page. For background on the condition itself, see this overview of opioid use disorder.
Pregnancy, court-ordered care, and Casey’s Law
A few situations in Kentucky come with specific paths. For pregnant patients, methadone and buprenorphine are the recommended standard of care, and treatment lowers risk for both parent and baby; a clinician coordinates prenatal care and prepares for neonatal opioid withdrawal syndrome (NOWS) if it applies. Kentucky requires buprenorphine prescribers to screen for pregnancy and connect pregnant patients with obstetric care. Treatment, not avoiding care, is what protects the pregnancy, and this resource on methadone during pregnancy goes deeper. Kentucky also has Casey’s Law (the Matthew Casey Wethington Act), which lets family members petition a court to order treatment for a loved one who cannot seek it themselves; families weighing that step can start with this guide to supporting someone in treatment.
Naloxone and overdose safety
Naloxone, the medication that reverses an opioid overdose, is available in Kentucky at pharmacies without a personal prescription under a statewide pharmacist protocol (Senate Bill 192), and through community distribution. In Lexington, the Lexington-Fayette County Health Department’s Harm Reduction Services and outreach workers distributed thousands of naloxone kits across 2024 and early 2025. Kentucky’s Good Samaritan Law (KRS 218A.133) protects someone who calls 911 for an overdose from prosecution for drug possession if they stay with the person and were acting in good faith. Keeping naloxone on hand is worth it for anyone using opioids or close to someone who does, and a return to use is a common, manageable part of recovery, not a failure. This page on recognizing and responding to an overdose has more.
Common questions about treatment in Lexington
Do I have to go to a clinic every day for methadone?
At first, usually yes. Methadone for opioid use disorder is dispensed through an opioid treatment program, and dosing starts daily. As you stabilize, federal rules updated in 2024 allow take-home supplies of up to 28 days, decided by the program based on your progress.
Can I get Suboxone without going to a methadone clinic?
Yes. Buprenorphine, including Suboxone, can be prescribed in a doctor’s office by any clinician with a standard DEA registration and filled at a pharmacy. It is also offered at OTPs. That gives you more setting choices than methadone.
Is treatment just replacing one drug with another?
No. This is a common misconception. Methadone and buprenorphine are prescribed, steady doses that normalize brain function and cut overdose death risk by more than half, according to SAMHSA and NIDA. They are legitimate medical treatment, and long-term use is appropriate care, not an unfinished step. You can read more in this explanation of methadone and dependence.
Can I start treatment by telehealth?
Often, yes, for buprenorphine, including by phone in many cases, under rules current through the end of 2026. Methadone can be started by telehealth only through an OTP using audio-video. Confirm what a specific Lexington provider offers when you call.
What does treatment cost if I have Medicaid?
Kentucky Medicaid covers all three medications for opioid use disorder through its managed care plans. Buprenorphine no longer requires prior authorization for the combination tablet. Ask the program to verify your specific plan at intake.
Last reviewed and disclosures
Last reviewed July 2026.
Sources
- City of Lexington, “Fatal overdose deaths decline in Fayette,” 2025.
- Lexington-Fayette County Health Department, fentanyl and overdose data, 2025.
- Kentucky Injury Prevention and Research Center, Kentucky Resident Drug Overdose Deaths reports, 2025 and 2026.
- SAMHSA, Medications for Opioid Use Disorder overview and 2024 revision of 42 CFR Part 8.
- DEA and HHS, Fourth Temporary Extension of Telemedicine Flexibilities, effective January 1 through December 31, 2026.
- Kentucky Cabinet for Health and Family Services, Department for Medicaid Services, MOUD coverage.
- Kentucky Revised Statutes 218A.133 (Good Samaritan Law) and 217.186; Senate Bill 192 (naloxone access).
- Kentucky Board of Medical Licensure, 201 KAR 9:270 (buprenorphine prescribing standards).
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com does not endorse any treatment facility or guarantee the quality of care provided, or the results to be achieved, by any treatment facility. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline on this site will be answered or returned by a paid advertiser. We do not receive any commission or fee dependent upon which treatment provider a caller chooses, and there is no obligation to enter treatment.